Clinical Trials
3 trialsNCT03761225 2023-09-29
Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer
AB Science
Phase 3 Completed
NCT03236688 2022-10-06
Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)
Exosome Diagnostics, Inc.
Suspended
NCT01732549 2019-11-22
A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy
Ipsen
Phase 2 Terminated